ClinicalTrials.Veeva

Menu

Effect of a Novel Protein Ingredient Combined With Oral Nutritional Supplement on Appetite in Older Adults

University College Dublin logo

University College Dublin

Status

Active, not recruiting

Conditions

Aging
Undernutrition
Appetite Loss

Treatments

Dietary Supplement: Oral Nutritional Supplement
Dietary Supplement: Oral Nutritional Supplement + Whey Protein Hydrolysate
Dietary Supplement: Whey Protein Hydrolysate + still water

Study type

Interventional

Funder types

Other

Identifiers

NCT06478147
LS-22-64-Horner#2

Details and patient eligibility

About

Reduced appetite can occur with ageing and is linked to a higher risk of undernutrition, poorer physical function and becoming frail. Strategies to increase appetite are needed to improve healthy ageing. This study follows on from previous work which has found a novel ingredient in whey protein (derived from whole milk) that may help to increase appetite and energy intake. This study will compare the effects of the ingredient added to an oral nutritional supplement (ONS) versus the ONS alone versus the ingredient dissolved in water on appetite in older adults. By studying this nutrition supplement in older adults, this will help to provide greater information on possible nutrition strategies to improve healthy ageing.

Enrollment

17 patients

Sex

All

Ages

60 to 120 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Community-dwelling,
  • Age 60+ years
  • Poor appetite (Simplified Nutritional Appetite Questionnaire (SNAQ) score </=14, answer a, b or c to Q.1 on SNAQ or answer b, c, or d to CES-D question regarding poor appetite in the past week)
  • BMI 20-25kg/m2

Exclusion criteria

  • Current medical condition or medication known to impact appetite or energy intake
  • Other medical condition that would impact study participation and outcomes, as judged by the study investigator.
  • Heavy smoker (>10/day)
  • Inability to come to study centre
  • Currently participating in another intervention study
  • Lacking informed consent
  • Allergic to or unwilling to consume any of the study test foods
  • Loss of taste or smell associated with COVID-19
  • Unable to walk across a room

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

17 participants in 3 patient groups, including a placebo group

Oral Nutritional Supplement
Placebo Comparator group
Description:
125 mL of commercially available of Oral Nutritional Supplement, a liquid food product containing vitamins, minerals, protein, fats and carbohydrates. 125 mL of product provides 37.0 g of carbohydrates, 11.6 g of fats, 12.0 g of proteins, vitamins and minerals.
Treatment:
Dietary Supplement: Oral Nutritional Supplement
Oral Nutritional Supplement + Whey Protein Hydrolysate
Experimental group
Description:
2,2 grams of whey protein hydrolysate dissolved in 125 mL of commercially available of Oral Nutritional Supplement
Treatment:
Dietary Supplement: Oral Nutritional Supplement + Whey Protein Hydrolysate
Whey Protein Hydrolysate
Active Comparator group
Description:
2,2 grams of whey protein hydrolysate dissolved in 125 mL of water
Treatment:
Dietary Supplement: Whey Protein Hydrolysate + still water

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems